Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

HON

Honeywell Announces Aerospace Spin-Off Details

Honeywell’s board has set June 15, 2026 as the record date for the planned spin-off of Honeywell Aerospace, with the distribution expected on June 29, 2026.

Shareowners on the record date are expected to receive 1 share of Honeywell Aerospace for every 2 shares of Honeywell common stock they own. Honeywell Aerospace is expected to start trading on Nasdaq the same day, June 29, under the ticker “HONA,” while Honeywell will continue trading under “HON.”

Ahead of the separation, Honeywell expects when-issued trading for the aerospace business to begin on or about June 15 under the symbol “HONAV.” From June 15 through June 26, Honeywell stock is expected to trade in two markets: “HON” with the right to receive Aerospace shares, and “HONIV” without that right.

Honeywell also said it will complete a 1-for-2 reverse stock split on June 29, contingent on the spin-off. That will cut Honeywell’s issued and outstanding shares from about 634 million to about 317 million. At the same time, authorized shares will be reduced from 2 billion to 1 billion.

The reverse split means every 2 Honeywell shares will become 1 share, with no fractional shares issued. Fractional interests will be sold and shareholders will receive cash proceeds from those sales. Honeywell said equity awards and shares under benefit plans will be adjusted proportionately.

The company said the spin-off is part of its broader portfolio separation, with Honeywell Aerospace set to operate as a standalone pure-play aerospace supplier focused on commercial and defense markets. Following these announcements, the company's shares moved -1.69%, and are now trading at a price of $213.97. For the full picture, make sure to review HONEYWELL INTERNATIONAL INC's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS